CTRad has four workstreams that focus on different aspects of radiotherapy research; they meet all together at least once a year, and individually two to four times per year.
The science base workstream focuses on preclinical studies, radiation-drug interactions, radiobiology, biomarkers and imaging and physics and imaging.
Members:
Nicola Curtin (co-chair)
Shree Bhide
Ross Carruthers
Mark Hill
Barbara Pedley
Paul Shaw
Samantha Terry
Gillian Tozer
Vessela Vassileva
Tim Humphrey (consumer member)
The phase I/II studies workstream focusses on phase I/II studies, experimental cancer medicine, biomarkers and imaging and systemic therapies and radiotherapy.
Members:
Richard Adams (co-chair)
Sarah Brown (co-chair)
Richard Baird
Sean Buckland
Ananya Choudhury
Martin Forster
Jo Haviland
Andrew Scarsbrook
Tim Ward (consumer member)
The phase III trials and methodology workstream focusses on phase III trials, links with NCRI Groups and trials methodology development for evaluating novel radiotherapy approaches.
Members:
Robert Huddart (co-chair)
Yat Man Tsang (co-chair)
Ane Appelt
Corinne Faivre-Finn
Duncan Gilbert
Emma Hall
Chris Hurt
Anna Kirby
Louise Murray
Lucy McParland
Beatrice Seddon
Deborah Keatley (consumer member)
Richard Stephens (consumer member)
The new technology, physics and quality assurance workstream focusses on new technologies (e.g. proton therapy, stereotactic body radiotherapy, functional imaging), quality assurance, radiotherapy physics and databases.
Members:
Karen Kirkby (co-chair)
Antony Carver
David Cutter
Aileen Duffton
Teresa Guerrero-Urbano
Sarah Gulliford
Shaista Hafeez
Jamie McClelland
Christopher South
Julie Wolfarth (consumer member)